The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment

被引:103
作者
Shoham, T
Rajapaksa, R
Boucheix, C
Rubinstein, E
Poe, JC
Tedder, TF
Levy, S
机构
[1] Stanford Univ, Med Ctr, Dept Med, Div Oncol, Stanford, CA 94305 USA
[2] Hop Paul Brousse, INSERM Unite 268, Inst Andre Lwoff, Villejuif, France
[3] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA
关键词
D O I
10.4049/jimmunol.171.8.4062
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD81 is a widely expressed tetraspanin that associates in B cells with CD19 in the CD19-CD21-CD81 signaling complex. CD81 is necessary for normal CD19 expression; cd81(-/-) B cells express lower levels of CD19, especially cd81(-/-) small pre-BII cells, which are almost devoid of surface CD19. The dependence of CD19 expression on CD81 is specific to this particular tetraspanin since cd9(-/-) B cells express normal levels of CD19. Furthermore, expression of human CD81 in mouse cd81(-/-) B cells restored surface CD19 to normal levels. Quantitative analysis of CD19 mRNA demonstrated normal levels, even in cd81(-/-) pre-BII cells. Analysis of CD19 at the protein level identified two CD19 glycoforms in both wild-type and cd81(-/-) B cells. The higher Mr glycoform is significantly reduced in cd81(-/-) B cells and is endoglycosidase H (endo-H) resistant. In contrast, the low Mr glycoform is comparably expressed in cd81(-/-) and in wild-type B cells and is endo-H sensitive. Because endo-H sensitivity is tightly correlated with endoplasmic reticulum localization, we suggest that the dependency of CD19 expression on CD81 occurs in a postendoplasmic reticulum compartment where CD81 is necessary for normal trafficking or for surface membrane stability of CD19.
引用
收藏
页码:4062 / 4072
页数:11
相关论文
共 44 条
[1]   Tetraspanins [J].
Boucheix, C ;
Rubinstein, E .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (09) :1189-1205
[2]  
BRADBURY LE, 1992, J IMMUNOL, V149, P2841
[3]   The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens [J].
Cherukuri, A ;
Cheng, PC ;
Pierce, SK .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :163-172
[4]   Allergen-induced airway hyperreactivity is diminished in CD81-deficient mice [J].
Deng, J ;
Yeung, VP ;
Tsitoura, D ;
DeKruyff, RH ;
Umetsu, DT ;
Levy, S .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :5054-5061
[5]   Critical role of CD81 in cognate T-B cell interactions leading to Th2 responses [J].
Deng, J ;
Dekruyff, RH ;
Freeman, GJ ;
Umetsu, DT ;
Levy, S .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (05) :513-523
[6]   Setting the standards: Quality control in the secretory pathway [J].
Ellgaard, L ;
Molinari, M ;
Helenius, A .
SCIENCE, 1999, 286 (5446) :1882-1888
[7]   ABNORMAL B-LYMPHOCYTE DEVELOPMENT, ACTIVATION, AND DIFFERENTIATION IN MICE THAT LACK OR OVEREXPRESS THE CD19 SIGNAL-TRANSDUCTION MOLECULE [J].
ENGEL, P ;
ZHOU, LJ ;
ORD, DC ;
SATO, S ;
KOLLER, B ;
TEDDER, TF .
IMMUNITY, 1995, 3 (01) :39-50
[8]   Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex [J].
Fearon, DT ;
Carroll, MC .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :393-422
[9]   THE CD19/CR2/TAPA-1 COMPLEX OF B-LYMPHOCYTES - LINKING NATURAL TO ACQUIRED-IMMUNITY [J].
FEARON, DT ;
CARTER, RH .
ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 :127-149
[10]   Release and intercellular transfer of cell surface CD81 via microparticles [J].
Fritzsching, B ;
Schwer, B ;
Kartenbeck, J ;
Pedal, A ;
Horejsi, V ;
Ott, M .
JOURNAL OF IMMUNOLOGY, 2002, 169 (10) :5531-5537